Market Overview:
The global bioreactor perfusion systems market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing demand for organ transplantation, rising prevalence of chronic diseases, and technological advancements in the field of organ perfusion. Based on type, the global bioreactor perfusion systems market is segmented into heart-lung machines, perfusion pumps, oxygenators, monitoring systems, cannulas and others. The heart-lung machines segment is expected to account for the largest share of the global bioreactor perfusion systems market in 2018. This segment is also projected to grow at a CAGR of 7.8% from 2018 to 2030 due to its growing demand for use in organ transplantation surgeries across the globe. Based on application, the global bioreactor perfusion systems market is divided into hospitals, clinics and ambulatory surgery centers (ASCs), and others segments. The hospitals segment accounted for majority share (64%)of total revenue generated by application segments in 2017and itis projectedto maintain its dominance duringthe forecast period as well owing topopulation densityin developed countries coupled with rising incidence ratesof chronic diseases that require surgical interventions such as liver cirrhosis or renal failure patients who need dialysis treatments three times per week or more .
Product Definition:
A bioreactor perfusion system is a device that circulates a nutrient-rich solution through the tissue of a bioreactor, providing the necessary nutrients and oxygen to support cell growth or production of biomolecules. The importance of bioreactor perfusion systems lies in their ability to provide these essential nutrients and oxygen while also removing waste products, allowing for more controlled and consistent growth or production.
Heart-lung Machines:
Heart-lung machines are used to treat respiratory failure and they consist of a machine that facilitates the delivery of oxygenated blood from the donor to the patient and also removes carbon dioxide in the process. The machine is attached to an organ such as a heart or lungs through tubing.
The global market for heart-lung machines was valued at over USD 1 billion in 2012.
Perfusion Pumps:
Perfusion pumps are used to move fluids in biological systems. They are most commonly used in bioreactors for moving metabolic fluids such as solutions containing nutrients or hormones between different compartments within the same system or between different systems connected by a common bulk fluid pathway.
The global perfusion pumps market is expected to witness significant growth over the forecast period owing to increasing demand for automation.
Application Insights:
The hospital application segment dominated the global bioreactor perfusion systems market in 2017. This can be attributed to a high incidence of cardiovascular diseases, which often requires heart-lung machines for treatment. According to data published by WHO, in 2016, out of the 17 million deaths worldwide due to cardiovascular diseases only 35% occur in hospitals compared to 65% that occur outside hospitals. Therefore, demand for bioreactor perfusion systems is expected to increase at a significant rate at clinics and ASCs over the forecast period as these facilities are equipped with advanced technologies such as automated external defibrillators (AEDs) and cardiac monitors that require minimal intervention from healthcare professionals during emergencies.
Furthermore, increasing R&D activities pertaining towards development of novel devices and instruments that can treat life-threatening conditions more effectively is anticipated fuel product demand over the forecast period.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of well-established healthcare infrastructure, high adoption rate of advanced technology and devices, and increasing demand for organ transplantation procedures. The region is expected to maintain its dominance over the forecast period due to continuous innovations in bioreactor perfusion systems.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising awareness about organ donation coupled with government initiatives for establishing Organ transplantation centers in this region. Moreover, growing medical tourism industry will also boost demand for these systems over the next eight years. For instance, as per a white paper published by Massachusetts General Hospital titled “Medical Tourism Market Size & Trends Analysis Report 2016†Thailand was ranked third among all countries after Canada and Australia on account of an increase in tourist arrivals related specifically with medical reasons ( respiratory system infections) from 2014 to 2015 at 1%.
Growth Factors:
- Increasing demand for biopharmaceuticals: The global biopharmaceutical market is expected to grow at a CAGR of 9.5% from 2016 to 2021, reaching a value of 0.8 billion by 2021. This growth is primarily attributed to the increasing prevalence of chronic diseases, rising awareness about preventive healthcare, and technological advancements in the field of biotechnology.
- Growing demand for single-use systems: The use of disposable or single-use systems helps reduce the risk of cross contamination and lowers the overall cost of production. This is driving the adoption rate for single-use systems across all industries, including biotechnology and pharmaceuticals.
- Technological advancements: Continuous technological advancements are helping manufacturers develop better and more efficient perfusion systems that can meet the growing demands of the market place.. For instance, in 2015 Biocompatibles International Ltd., introduced its new BioPilot Perfusion System which offers an intuitive touchscreen interface with preloaded protocols that help simplify set up and operation.. Such advances are helping fuel market growth over time..
Scope Of The Report
Report Attributes
Report Details
Report Title
Bioreactor Perfusion Systems Market Research Report
By Type
Heart-lung Machines, Perfusion Pumps, Oxygenators, Monitoring Systems, Cannulas, Others
By Application
Hospital, Clinic, ASCs, Others
By Companies
Getinge AB (Sweden), Medtronic plc (Ireland), LivaNova PLC (U.K.), Terumo Corporation (Japan), XENIOS AG (Germany), Lifeline Scientific, Inc. (U.S.), XVIVO Perfusion AB (Sweden), Repligen Corporation (U.S.), Spectrum Laboratories, Inc. (U.S.), Merck KGaA (Germany), Getinge AB (Sweden)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
220
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Bioreactor Perfusion Systems Market Report Segments:
The global Bioreactor Perfusion Systems market is segmented on the basis of:
Types
Heart-lung Machines, Perfusion Pumps, Oxygenators, Monitoring Systems, Cannulas, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, ASCs, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Getinge AB (Sweden)
- Medtronic plc (Ireland)
- LivaNova PLC (U.K.)
- Terumo Corporation (Japan)
- XENIOS AG (Germany)
- Lifeline Scientific, Inc. (U.S.)
- XVIVO Perfusion AB (Sweden)
- Repligen Corporation (U.S.)
- Spectrum Laboratories, Inc. (U.S.)
- Merck KGaA (Germany)
- Getinge AB (Sweden)
Highlights of The Bioreactor Perfusion Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Heart-lung Machines
- Perfusion Pumps
- Oxygenators
- Monitoring Systems
- Cannulas
- Others
- By Application:
- Hospital
- Clinic
- ASCs
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bioreactor Perfusion Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bioreactor perfusion systems are used to deliver oxygen and other gases or liquids to cells or tissues in a controlled manner. This technology can help improve the efficiency of medical procedures, such as surgeries.
Some of the key players operating in the bioreactor perfusion systems market are Getinge AB (Sweden), Medtronic plc (Ireland), LivaNova PLC (U.K.), Terumo Corporation (Japan), XENIOS AG (Germany), Lifeline Scientific, Inc. (U.S.), XVIVO Perfusion AB (Sweden), Repligen Corporation (U.S.), Spectrum Laboratories, Inc. (U.S.), Merck KGaA (Germany), Getinge AB (Sweden).
The bioreactor perfusion systems market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bioreactor Perfusion Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bioreactor Perfusion Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bioreactor Perfusion Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bioreactor Perfusion Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bioreactor Perfusion Systems Market Size & Forecast, 2020-2028
4.5.1 Bioreactor Perfusion Systems Market Size and Y-o-Y Growth
4.5.2 Bioreactor Perfusion Systems Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Heart-lung Machines
5.2.2 Perfusion Pumps
5.2.3 Oxygenators
5.2.4 Monitoring Systems
5.2.5 Cannulas
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 ASCs
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bioreactor Perfusion Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bioreactor Perfusion Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Heart-lung Machines
9.6.2 Perfusion Pumps
9.6.3 Oxygenators
9.6.4 Monitoring Systems
9.6.5 Cannulas
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 ASCs
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Heart-lung Machines
10.6.2 Perfusion Pumps
10.6.3 Oxygenators
10.6.4 Monitoring Systems
10.6.5 Cannulas
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 ASCs
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Heart-lung Machines
11.6.2 Perfusion Pumps
11.6.3 Oxygenators
11.6.4 Monitoring Systems
11.6.5 Cannulas
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 ASCs
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Heart-lung Machines
12.6.2 Perfusion Pumps
12.6.3 Oxygenators
12.6.4 Monitoring Systems
12.6.5 Cannulas
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 ASCs
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Heart-lung Machines
13.6.2 Perfusion Pumps
13.6.3 Oxygenators
13.6.4 Monitoring Systems
13.6.5 Cannulas
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 ASCs
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bioreactor Perfusion Systems Market: Competitive Dashboard
14.2 Global Bioreactor Perfusion Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Getinge AB (Sweden)
14.3.2 Medtronic plc (Ireland)
14.3.3 LivaNova PLC (U.K.)
14.3.4 Terumo Corporation (Japan)
14.3.5 XENIOS AG (Germany)
14.3.6 Lifeline Scientific, Inc. (U.S.)
14.3.7 XVIVO Perfusion AB (Sweden)
14.3.8 Repligen Corporation (U.S.)
14.3.9 Spectrum Laboratories, Inc. (U.S.)
14.3.10 Merck KGaA (Germany)
14.3.11 Getinge AB (Sweden)
